Page 29 - Advanced Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Is Brazos Valley becoming the Biotech Valley of Texas? generic image and last updated 2021-03-05 18:30:25-05 BRAZOS VALLEY, TX — Over the last decade, the Center for Innovation in Advanced Development and Manufacturing, CIADM, at Texas A&M’s Health Science Center has partnered with biotech companies in the Brazos valley to accelerate research, development, and commercial manufacturing. On March 3, one of the most recent companies to move to College Station, Matica Biotechnology, joined the ranks of biotech companies partnering with CIADM. “So, it’s a unique partnership th...

Misguided CBD brands in last minute novel foods panic, ACI warns Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned. The Food Standards Agency UK (FSA) has given CBD companies a deadline of 31 st​ March 2021 to have a validated Novel Food License application submitted and many finished product brands may think they have done all they need to do. But Shomi Malik, external affairs director at th...

02/27/2021 | Press release | Distributed by Public on 02/27/2021 19:28 Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine, February 27, 2021 News Release Saturday, February 27, 2021 Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine, February 27, 2021 Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725. The Janssen vaccine is a...

News Release Saturday, February 27, 2021 Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725. The Janssen vaccine is a recombinant vector vaccine that uses a human adenovirus to express the spike protein found on the surface of the SARS-CoV-2 virus that causes COVID-19. Adenoviruses are a group of viruses that cause infections in the respiratory and gastrointestinal tracts; the adenovirus vector used in the Janssen COVID-19...

Share this article Share this article SANTA BARBARA, Calif., Feb. 22, 2021 /PRNewswire/ -- Cognixion®, a neural interface startup, introduces a new category of wearable combining Brain-Computer Interface (BCI) with Augmented Reality (AR). Say "Hello" with Cognixion ONE™. (PRNewsfoto/Cognixion) Cognixion's history of developing products for individuals with disabilities has let them to understand their needs and invent new adaptive interfaces that also makes technology easier to use by everyone. According to Neurotech.com's Global NeuroTech Industry Landscape Overview 2020 report 1, Cognix...